Key Takeaway
Umbrella review of 40+ meta-analyses confirms intermittent fasting significantly reduces body weight, BMI, and fat mass with comparable metabolic improvements to continuous energy restriction.
Summary
This updated umbrella review synthesized evidence from over 40 meta-analyses of randomized controlled trials examining intermittent fasting (IF) protocols, including time-restricted eating, alternate-day fasting, and the 5:2 diet. The review evaluated IF's effects on weight management, body composition, glycemic control, lipid profiles, blood pressure, and inflammatory markers.
Across multiple IF protocols, the review found consistent and significant reductions in body weight, BMI, waist circumference, and fat mass. Metabolic outcomes including fasting glucose, insulin resistance (HOMA-IR), triglycerides, total cholesterol, and blood pressure also showed meaningful improvements. Importantly, the review found that IF protocols were generally comparable to continuous calorie restriction for most outcomes, suggesting that the timing-based approach offers a viable alternative rather than a clearly superior method.
The review highlighted that time-restricted eating (typically 8-hour or shorter windows) was particularly well-studied and showed robust benefits for metabolic health markers. However, the authors noted heterogeneity across studies and called for more long-term trials to assess sustainability and safety over years rather than weeks or months.
Methods
Umbrella review methodology synthesizing meta-analyses of randomized controlled trials. The authors systematically searched multiple databases for meta-analyses examining any form of intermittent fasting. Each included meta-analysis was assessed for quality using AMSTAR-2 criteria. Outcomes were categorized by IF protocol type and health domain. The review covered weight management, body composition, glycemic markers, lipid profiles, blood pressure, and inflammation.
Key Results
- Intermittent fasting significantly reduced body weight, BMI, waist circumference, and fat mass across multiple meta-analyses
- Fasting glucose, HOMA-IR, HbA1c, and insulin levels improved significantly
- Triglycerides, total cholesterol, and LDL cholesterol were reduced; HDL showed variable results
- Systolic and diastolic blood pressure decreased significantly
- IF was comparable to continuous energy restriction for most weight and metabolic outcomes
- Time-restricted eating and alternate-day fasting showed the most consistent evidence
Limitations
- Most included meta-analyses covered trials of 12 weeks or shorter, limiting conclusions about long-term effects
- Significant heterogeneity across studies in IF protocols, populations, and outcome measures
- Quality of included meta-analyses varied; some had methodological limitations
- Unable to determine optimal IF protocol, window duration, or timing from available evidence
- Limited data on safety in specific populations (elderly, diabetics, those with eating disorder history)